Rebecca G Nowak1, Patti E Gravitt, Xin He, Sosthenes Ketende, Wuese Dauda, Helen Omuh, William A Blattner, Manhattan E Charurat. 1. From the *Institute of Human Virology and †Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD; ‡University of New Mexico Health Sciences Center, Albuquerque, NM; §University of Maryland School of Public Health, College Park, MD; ¶Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; and ∥Institute of Human Virology Nigeria, Federal Capital Territory, Nigeria.
Abstract
BACKGROUND: Prevalence estimates of anal high-risk human papillomavirus (HR-HPV) are needed in sub-Saharan Africa where HIV is endemic. This study evaluated anal HR-HPV in Nigeria among HIV-positive and HIV-negative men who have sex with men (MSM) for future immunization recommendations. METHODS: We conducted a cross-sectional study to compare the prevalence of anal HR-HPV infections between 64 HIV-negative and 90 HIV-positive MSM. Multivariate Poisson regression analyses were used to examine demographic and behavioral risk factors associated with any HR-HPV infections. RESULTS: The median age of the 154 participants was 25 years (interquartile range, 22-28 years; range, 16-38 years), and the median age at initiation of anal sex with another man was 16 years (interquartile range, 13-18 years; range, 7-29 years). The prevalence of anal HR-HPV was higher among HIV-positive than HIV-negative MSM (91.1% vs. 40.6%, P < 0.001). In the multivariate analysis, HIV infection (adjusted prevalence ratio [aPR], 2.02; 95% confidence interval [CI], 1.49-2.72), 10 years or more since anal sexual debut (aPR, 1.26; 95% CI, 1.07-1.49), and concurrent relationships with men (aPR, 1.32; 95% CI, 1.04-1.67) were associated with increased anal HR-HPV prevalence. CONCLUSIONS: Anal HR-HPV infection is high for young Nigerian MSM, and rates are amplified in those coinfected with HIV. Providing universal coverage as well as catch-up immunization for young MSM may be an effective anal cancer prevention strategy in Nigeria.
BACKGROUND: Prevalence estimates of anal high-risk human papillomavirus (HR-HPV) are needed in sub-Saharan Africa where HIV is endemic. This study evaluated anal HR-HPV in Nigeria among HIV-positive and HIV-negative men who have sex with men (MSM) for future immunization recommendations. METHODS: We conducted a cross-sectional study to compare the prevalence of anal HR-HPV infections between 64 HIV-negative and 90 HIV-positive MSM. Multivariate Poisson regression analyses were used to examine demographic and behavioral risk factors associated with any HR-HPV infections. RESULTS: The median age of the 154 participants was 25 years (interquartile range, 22-28 years; range, 16-38 years), and the median age at initiation of anal sex with another man was 16 years (interquartile range, 13-18 years; range, 7-29 years). The prevalence of anal HR-HPV was higher among HIV-positive than HIV-negative MSM (91.1% vs. 40.6%, P < 0.001). In the multivariate analysis, HIV infection (adjusted prevalence ratio [aPR], 2.02; 95% confidence interval [CI], 1.49-2.72), 10 years or more since anal sexual debut (aPR, 1.26; 95% CI, 1.07-1.49), and concurrent relationships with men (aPR, 1.32; 95% CI, 1.04-1.67) were associated with increased anal HR-HPV prevalence. CONCLUSIONS:Anal HR-HPV infection is high for young Nigerian MSM, and rates are amplified in those coinfected with HIV. Providing universal coverage as well as catch-up immunization for young MSM may be an effective anal cancer prevention strategy in Nigeria.
Authors: Nicky McCreesh; Simon D W Frost; Janet Seeley; Joseph Katongole; Matilda N Tarsh; Richard Ndunguse; Fatima Jichi; Natasha L Lunel; Dermot Maher; Lisa G Johnston; Pam Sonnenberg; Andrew J Copas; Richard J Hayes; Richard G White Journal: Epidemiology Date: 2012-01 Impact factor: 4.822
Authors: Alan G Nyitray; Roberto J Carvalho da Silva; Maria Luiza Baggio; Beibei Lu; Danélle Smith; Martha Abrahamsen; Mary Papenfuss; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano Journal: J Infect Dis Date: 2011-01-01 Impact factor: 5.226
Authors: Edgar P Simard; Meg Watson; Mona Saraiya; Christina A Clarke; Joel M Palefsky; Ahmedin Jemal Journal: Cancer Date: 2013-07-16 Impact factor: 6.860
Authors: Fleur van Aar; Sofie H Mooij; Marianne A B van der Sande; Arjen G C L Speksnijder; Ineke G Stolte; Chris J L M Meijer; Dominique W M Verhagen; Audrey J King; Henry J C de Vries; Maarten F Schim van der Loeff Journal: AIDS Date: 2013-11-28 Impact factor: 4.177
Authors: Dorothy J Wiley; Xiuhong Li; Hilary Hsu; Eric C Seaberg; Ross D Cranston; Stephen Young; Gypsyamber D'Souza; Otoniel Martínez-Maza; Katherine DeAzambuja; Kristofer Chua; Shehnaz K Hussain; Roger Detels Journal: PLoS One Date: 2013-11-20 Impact factor: 3.240
Authors: Rebecca G Nowak; Søren M Bentzen; Jacques Ravel; Trevor A Crowell; Wuese Dauda; Bing Ma; Hongjie Liu; William A Blattner; Stefan D Baral; Manhattan E Charurat Journal: AIDS Date: 2017-03-27 Impact factor: 4.177
Authors: Rebecca G Nowak; Nicholas P Ambulos; Lisa M Schumaker; Trevor J Mathias; Ruth A White; Jennifer Troyer; David Wells; Manhattan E Charurat; Søren M Bentzen; Kevin J Cullen Journal: Virol J Date: 2017-06-13 Impact factor: 4.099
Authors: Sarah J Robbins; Wuese Dauda; Afoke Kokogho; Nicaise Ndembi; Andrew Mitchell; Sylvia Adebajo; Charlotte A Gaydos; Sheila Peel; Habib O Ramadhani; Merlin L Robb; Stefan D Baral; Julie A Ake; Man E Charurat; Trevor A Crowell; Rebecca G Nowak Journal: PLoS One Date: 2020-09-04 Impact factor: 3.240
Authors: Jessica A Kahn; Marvin Belzer; Xiaofei Chi; Jeannette Lee; Aditya H Gaur; Kenneth Mayer; Jaime Martinez; Donna C Futterman; Elizabeth A Stier; Mary E Paul; Elizabeth Y Chiao; Daniel Reirden; Steven E Goldstone; Ana P Ortiz Martinez; Edward R Cachay; Luis F Barroso; Maria Da Costa; Craig M Wilson; Joel M Palefsky Journal: Papillomavirus Res Date: 2019-01-15
Authors: Rebecca G Nowak; Nicaise Ndembi; Wuese Dauda; Paul Jibrin; Søren M Bentzen; Chinedu H Nnaji; Oluwole Olaomi; Teresa M Darragh; Jonathan Madukwe; Trevor A Crowell; Stefan D Baral; William A Blattner; Manhattan E Charurat; Joel M Palefsky; Kevin J Cullen Journal: J Glob Oncol Date: 2019-07
Authors: Gad Murenzi; Hae-Young Kim; Athanase Munyaneza; Patrick Tuyisenge; Thierry M Zawadi; Alex M Buteera; Adebola Adedimeji; Leon Mutesa; Philip E Castle; Kathryn Anastos; Joel M Palefsky Journal: J Acquir Immune Defic Syndr Date: 2020-08-15 Impact factor: 3.771